NEW YORK — MRC Holland said on Thursday that its blood-based assay for Temple, Kagami-Ogata, and Russell-Silver syndromes has received certification under Europe's In Vitro Diagnostic Regulation (IVDR ...
Introduction to Newborn Screening InstrumentsNewborn screening is a critical medical process that involves testing newborns for certain genetic, metabolic, and congenital conditions. The objective is ...
PTC Therapeutics (PTCT) saw its shares surge in the last session with trading volume being higher than average. The latest ...
PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...
The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...
12 天on MSN
The 18-year-old's mom and sister work hard to give her the life she deserves as she battles a rare genetic condition ...
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
14 天
Asian News International on MSNEmirates Health Services showcases innovative family health services at Arab Health 2025Under Emirates Health Services (EHS) theme "Future Health Now", EHS is participating in the 50th edition of Arab Health 2025, which kicks off tomorrow and runs until 30th January at the Dubai World ...
Genzyme Corp. (Sanofi Genzyme) has disclosed sodium-dependent neutral amino acid transporter B(0)AT1 (SLC6A19) inhibitors reported to be useful for the treatment of phenylketonuria, among others.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果